G1 Therapeutics Revenue 2016-2024 | GTHX
G1 Therapeutics revenue from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| G1 Therapeutics Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $83 |
| 2022 | $51 |
| 2021 | $31 |
| 2020 | $45 |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $1 |
| G1 Therapeutics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $17 |
| 2024-03-31 | $14 |
| 2023-12-31 | $15 |
| 2023-09-30 | $12 |
| 2023-06-30 | $42 |
| 2023-03-31 | $13 |
| 2022-12-31 | $10 |
| 2022-09-30 | $24 |
| 2022-06-30 | $11 |
| 2022-03-31 | $7 |
| 2021-12-31 | $6 |
| 2021-09-30 | $5 |
| 2021-06-30 | $7 |
| 2021-03-31 | $14 |
| 2020-12-31 | $17 |
| 2020-09-30 | $27 |
| 2020-06-30 | $2 |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2015-12-31 | |
